Prodigiosenes conjugated to tamoxifen and estradiol.
Fiche publication
Date publication
juin 2017
Journal
Organic & biomolecular chemistry
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FIGLIOLA Carlotta
Tous les auteurs :
Marchal E, Figliola C, Thompson A
Lien Pubmed
Résumé
We report the synthesis of the first click-appended prodigiosene conjugates. Four prodigiosene conjugates of estradiol functionalised at the 7α-position were prepared, as were three prodigiosene conjugates of tamoxifen. The coupling between a prodigiosene and an 11-hydroxy estradiol derivative via an ether linkage was investigated, as was the 11- and 7-functionalisation of the estradiol core. The robustness of estradiol protecting groups was severely challenged by reactions typically used to equip such frameworks for 11- and 7-functionalisation. Specifically, and important to synthesis involving estradiol, TBS, TMS and THP are not useful protecting groups for the functionalisation of this core. When the chemical features of the therapeutic agent limit the choice of protecting group (in this case, prodigiosenes bearing aryl, NH, alkenyl and ester groups), click chemistry becomes an attractive synthetic strategy. The anti-cancer activity of the seven click prodigiosene conjugates was evaluated.
Mots clés
Antineoplastic Agents, chemical synthesis, Cell Line, Tumor, Cell Proliferation, drug effects, Click Chemistry, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Estradiol, chemistry, Humans, Molecular Structure, Prodigiosin, chemistry, Structure-Activity Relationship, Tamoxifen, chemistry
Référence
Org Biomol Chem. 2017 06 27;15(25):5410-5427